DR. JORGE AYUB M.D. NPI 1902876162

NPI Details

DR. Jorge Ayub, M.D. is a medical oncology internal medicine in Hudson, FL with 50 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Jorge Ayub, M.D. NPI is 1902876162. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

7651 MEDICAL DR
HUDSON, FL
ZIP 34667-594
Phone: (727) 868-9208
Fax: (727) 863-8725

The NPI 1902876162 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Blood test, clotting time (HCPCS:85610)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Magnesium level (HCPCS:83735)
• Injection of drug or substance into vein (HCPCS:96374)
• Drawing of blood for a medical problem (HCPCS:99195)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Protein measurement, serum (HCPCS:84165)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• Measurement of immunoglobulin light chains (HCPCS:83521)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Red blood count, manual test (HCPCS:85044)

The enumeration date for this NPI number is 1/23/2006 and was last updated on 8/2/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.